Cargando…
Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children
BACKGROUND: Little is known about mucocutaneous disease in acutely ill children and adolescents with COVID-19 and multisystem inflammatory syndrome in children (MIS-C). OBJECTIVE: To characterize mucocutaneous disease and its relation to clinical course among hospitalized patients with COVID-19 and...
Autores principales: | Rekhtman, Sergey, Tannenbaum, Rachel, Strunk, Andrew, Birabaharan, Morgan, Wright, Shari, Garg, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585496/ https://www.ncbi.nlm.nih.gov/pubmed/33323343 http://dx.doi.org/10.1016/j.jaad.2020.10.060 |
Ejemplares similares
-
Mucocutaneous manifestations among adults hospitalized with multisystem inflammatory syndrome following SARS-CoV-2 infection
por: Tannenbaum, Rachel, et al.
Publicado: (2022) -
Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19
por: Rekhtman, Sergey, et al.
Publicado: (2021) -
A response to “Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children’’
por: Sert, Ahmet
Publicado: (2021) -
340. Prevalence of Type II Diabetes Mellitus Among Patients Living with HIV in the United States
por: Birabaharan, Morgan, et al.
Publicado: (2019) -
Myriad of Mucocutaneous Manifestations in Multisystem Inflammatory Syndrome Associated with COVID-19
por: Prithvi, Ashwini, et al.
Publicado: (2023)